gms | German Medical Science

68th Annual Meeting of the German Society of Neurosurgery (DGNC)
7th Joint Meeting with the British Neurosurgical Society (SBNS)

German Society of Neurosurgery (DGNC)

14 - 17 May 2017, Magdeburg

Article

Send article

The Safety of Intraarterial Nimodipine Treatment of Severe Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage in Patients with Additional Unsecured Unruptured Intracranial Aneurysms

Meeting Abstract

Search Medline for

  • Josef Michael Lang - Department of Neurosurgery, Hannover, Deutschland
  • Friedrich Götz - Institut für Diagnostische und Interventionelle Neuroradiologie, Neuroradiologie, Hannover, Deutschland
  • Joachim K. Krauss - Medizinische Hochschule Hannover, Neurochirurgische Klinik, Klinik für Neurochirurgie, Hannover, Deutschland

Deutsche Gesellschaft für Neurochirurgie. Society of British Neurological Surgeons. 68. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), 7. Joint Meeting mit der Society of British Neurological Surgeons (SBNS). Magdeburg, 14.-17.05.2017. Düsseldorf: German Medical Science GMS Publishing House; 2017. DocDI.27.06

doi: 10.3205/17dgnc343, urn:nbn:de:0183-17dgnc3439

Published: June 9, 2017

© 2017 Lang et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.

Outline

Text

Objective: Selective intraarterial nimodipine administration is an established treatment option for patients with severe cerebral vasospasm after aneurysmal subarachnoid hemorrhage (aSAH). However, the safety in patients with additional unsecured unruptured intracranial aneurysms is unknown.

Methods: Analysis of a series of 97 patients treated with intraarterial nimodipine for severe medically refractory cerebral vasospasm according to a standardized regimen (2 mg nimodipine diluted with 20 ml 0,9 % NaCl and an infusion rate of 1 ml/min) after aSAH. The ruptured aneurysms were secured by clipping or coiling in all patients. 17 patients (17,5 %) were identified with a total of 21 coexisting unruptured unsecured intracranial aneurysms.

Results: There were 17 patients (3 men, 14 women with a mean age of 54,2 years, range 36-76 years). The unruptured unsecured intracranial aneurysms had a mean diameter of 3,6 mm (range 2-7 mm). The most frequent aneurysm locations were middle cerebral artery (8 aneurysms) and internal carotid artery (8 aneurysms). Two patients had multiple additional aneurysms (4 in one patient and 2 in the other). No aneurysm ruptured during therapy and no alteration of aneurysm configuration was radiologically observed. Furthermore, no other adverse effects were noted.

Conclusion: Selective intraarterial nimodipine application for treatment of severe cerebral vasospasm is safe in patients with coexisting small unsecured unruptured intracranial aneurysms.